NATURE’S SUNSHINE PRODUCTS, INC. Cost of Revenue
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Cost of Revenue of $30.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- NATURE’S SUNSHINE PRODUCTS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $30.81M, a 5.05% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $32.91M, a 3.99% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $34.03M, a 2.68% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $34.29M, a 4.36% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. cost of goods and services sold for fiscal 2025 was $132.42M, a 2.12% increase from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. cost of goods and services sold for fiscal 2024 was $129.68M, a 4.41% increase from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. cost of goods and services sold for fiscal 2023 was $124.19M, a 1.67% increase from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. cost of goods and services sold for fiscal 2022 was $122.15M, a 5.79% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.81M 10-Q · filed 2026-08-06 | $63.73M 10-Q · filed 2026-08-06 | $97.75M derived: sum of 3 quarters · filed 2026-08-06 | $132.04M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $32.91M 10-Q · filed 2026-05-07 | $66.94M derived: sum of 2 quarters · filed 2026-05-07 | $101.23M derived: sum of 3 quarters · filed 2026-05-07 | $133.68M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $34.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $68.32M derived: sum of 2 quarters · filed 2026-03-10 | $100.77M derived: sum of 3 quarters · filed 2026-08-06 | $132.42M 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $34.29M 10-Q · filed 2025-11-06 | $66.74M derived: sum of 2 quarters · filed 2026-08-06 | $98.39M 10-Q · filed 2025-11-06 | $131.53M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $32.45M 10-Q · filed 2026-08-06 | $64.10M 10-Q · filed 2026-08-06 | $97.24M derived: sum of 3 quarters · filed 2026-08-06 | $130.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $31.65M 10-Q · filed 2026-05-07 | $64.79M derived: sum of 2 quarters · filed 2026-05-07 | $97.65M derived: sum of 3 quarters · filed 2026-05-07 | $129.31M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $33.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $66.00M derived: sum of 2 quarters · filed 2026-03-10 | $97.66M derived: sum of 3 quarters · filed 2026-03-10 | $129.68M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $32.86M 10-Q · filed 2025-11-06 | $64.52M derived: sum of 2 quarters · filed 2025-11-06 | $96.53M 10-Q · filed 2025-11-06 | $127.15M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $31.66M 10-Q · filed 2025-07-31 | $63.68M 10-Q · filed 2025-07-31 | $94.29M derived: sum of 3 quarters · filed 2025-07-31 | $124.26M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-03-31 | $32.02M 10-Q · filed 2025-05-06 | $62.63M derived: sum of 2 quarters · filed 2025-05-06 | $92.59M derived: sum of 3 quarters · filed 2025-05-06 | $124.52M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $30.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $60.58M derived: sum of 2 quarters · filed 2025-03-11 | $92.50M derived: sum of 3 quarters · filed 2025-03-11 | $124.19M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $29.96M 10-Q · filed 2024-11-07 | $61.89M derived: sum of 2 quarters · filed 2024-11-07 | $93.58M 10-Q · filed 2024-11-07 | $122.17M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $31.92M 10-Q · filed 2024-08-08 | $63.62M 10-Q · filed 2024-08-08 | $92.20M derived: sum of 3 quarters · filed 2024-08-08 | $121.83M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $31.69M 10-Q · filed 2024-05-07 | $60.28M derived: sum of 2 quarters · filed 2024-05-07 | $89.91M derived: sum of 3 quarters · filed 2024-05-07 | $119.38M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $28.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $58.22M derived: sum of 2 quarters · filed 2024-03-12 | $87.69M derived: sum of 3 quarters · filed 2024-03-12 | $122.15M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | $29.63M 10-Q · filed 2023-11-07 | $59.10M derived: sum of 2 quarters · filed 2023-11-07 | $93.56M 10-Q · filed 2023-11-07 | $124.17M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $29.47M 10-Q · filed 2023-08-09 | $63.93M 10-Q · filed 2023-08-09 | $94.54M derived: sum of 3 quarters · filed 2023-08-09 | $123.96M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $34.46M 10-Q · filed 2023-05-09 | $65.07M derived: sum of 2 quarters · filed 2023-05-09 | $94.48M derived: sum of 3 quarters · filed 2023-05-09 | $122.95M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $30.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $60.02M derived: sum of 2 quarters · filed 2023-03-16 | $88.49M derived: sum of 3 quarters · filed 2023-03-16 | $115.47M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $29.42M 10-Q · filed 2022-11-03 | $57.88M derived: sum of 2 quarters · filed 2022-11-03 | $84.86M 10-Q · filed 2022-11-03 | $111.26M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $28.46M 10-Q · filed 2022-08-09 | $55.44M 10-Q · filed 2022-08-09 | $81.84M derived: sum of 3 quarters · filed 2022-08-09 | $109.02M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $26.98M 10-Q · filed 2022-05-05 | $53.38M derived: sum of 2 quarters · filed 2022-05-05 | $80.56M derived: sum of 3 quarters · filed 2022-05-05 | $103.57M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $26.40M 10-K · filed 2021-03-10 | $53.58M derived: sum of 2 quarters · filed 2021-11-04 | $76.59M derived: sum of 3 quarters · filed 2021-11-04 | $101.28M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | $27.18M 10-Q · filed 2021-11-04 | $50.19M derived: sum of 2 quarters · filed 2021-11-04 | $74.87M 10-Q · filed 2021-11-04 | $98.73M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $23.02M 10-Q · filed 2021-08-05 | $47.70M 10-Q · filed 2021-08-05 | $71.56M derived: sum of 3 quarters · filed 2021-08-05 | $94.34M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $24.68M 10-Q · filed 2021-05-06 | $48.54M derived: sum of 2 quarters · filed 2021-05-06 | $71.33M derived: sum of 3 quarters · filed 2021-05-06 | $95.19M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $23.86M 10-K · filed 2021-03-10 | $46.65M derived: sum of 2 quarters · filed 2021-03-10 | $70.51M derived: sum of 3 quarters · filed 2021-03-10 | $93.94M 10-K · filed 2021-03-10 | ||||
| 2019-09-30 | $22.78M 10-K · filed 2021-03-10 | $46.65M derived: sum of 2 quarters · filed 2021-03-10 | $70.08M 10-Q · filed 2020-11-09 | $95.62M derived: sum of 4 quarters · filed 2021-03-10 | ||||
| 2019-06-30 | $23.86M 10-K · filed 2021-03-10 | $47.29M 10-Q · filed 2020-08-06 | $72.83M derived: sum of 3 quarters · filed 2021-03-10 | $95.99M derived: sum of 4 quarters · filed 2021-03-10 | ||||
| 2019-03-31 | $23.43M 10-K · filed 2021-03-10 | $48.97M derived: sum of 2 quarters · filed 2021-03-10 | $72.13M derived: sum of 3 quarters · filed 2021-03-10 | $96.41M derived: sum of 4 quarters · filed 2021-03-10 | ||||
| 2018-12-31 | $25.54M 10-K · filed 2020-03-11 | $48.70M derived: sum of 2 quarters · filed 2020-03-11 | $72.98M derived: sum of 3 quarters · filed 2020-03-11 | $95.69M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $23.16M 10-K · filed 2020-03-11 | $47.44M derived: sum of 2 quarters · filed 2020-03-11 | $70.15M 10-Q · filed 2019-11-07 | $94.76M derived: sum of 4 quarters · filed 2020-03-11 | ||||
| 2018-06-30 | $24.28M 10-K · filed 2020-03-11 | $46.99M 10-Q · filed 2019-08-09 | $71.60M derived: sum of 3 quarters · filed 2020-03-11 | $95.10M derived: sum of 4 quarters · filed 2020-03-11 | ||||
| 2018-03-31 | $22.71M 10-K · filed 2020-03-11 | $47.32M derived: sum of 2 quarters · filed 2020-03-11 | $70.83M derived: sum of 3 quarters · filed 2020-03-11 | $92.02M derived: sum of 4 quarters · filed 2020-03-11 | ||||
| 2017-12-31 | $24.61M 10-K · filed 2019-03-08 | $48.11M derived: sum of 2 quarters · filed 2019-03-08 | $69.31M derived: sum of 3 quarters · filed 2019-03-08 | $91.04M 10-K · filed 2019-03-08 | ||||
| 2017-09-30 | $23.50M 10-K · filed 2019-03-08 | $44.70M derived: sum of 2 quarters · filed 2019-03-08 | $66.43M 10-Q · filed 2018-11-08 | $90.76M derived: sum of 4 quarters · filed 2019-03-08 | ||||
| 2017-06-30 | $21.20M 10-K · filed 2019-03-08 | $42.92M 10-Q · filed 2018-08-08 | $67.25M derived: sum of 3 quarters · filed 2019-03-08 | $88.76M derived: sum of 4 quarters · filed 2019-03-08 | ||||
| 2017-03-31 | $21.73M 10-K · filed 2019-03-08 | $46.05M derived: sum of 2 quarters · filed 2019-03-08 | $67.57M derived: sum of 3 quarters · filed 2019-03-08 | $90.64M derived: sum of 4 quarters · filed 2019-03-08 | ||||
| 2016-12-31 | $24.33M 10-K · filed 2018-03-16 | $45.84M derived: sum of 2 quarters · filed 2018-03-16 | $68.92M derived: sum of 3 quarters · filed 2018-03-16 | $90.94M 10-K · filed 2019-03-08 | ||||
| 2016-09-30 | $21.51M 10-K · filed 2018-03-16 | $44.59M derived: sum of 2 quarters · filed 2018-03-16 | $66.61M 10-Q · filed 2017-11-09 | $88.36M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $23.08M 10-K · filed 2018-03-16 | $45.10M 10-Q · filed 2017-08-09 | $66.85M derived: sum of 3 quarters · filed 2018-03-16 | $87.49M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $22.02M 10-K · filed 2018-03-16 | $43.77M derived: sum of 2 quarters · filed 2018-03-16 | $64.42M derived: sum of 3 quarters · filed 2018-03-16 | $85.48M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $21.75M 10-K · filed 2017-03-14 | $42.40M derived: sum of 2 quarters · filed 2017-03-14 | $63.46M derived: sum of 3 quarters · filed 2017-03-14 | $85.34M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $20.64M 10-K · filed 2017-03-14 | $41.71M derived: sum of 2 quarters · filed 2017-03-14 | $63.59M 10-Q · filed 2016-11-09 | $87.06M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | $21.07M 10-K · filed 2017-03-14 | $42.95M 10-Q · filed 2016-08-09 | $66.42M derived: sum of 3 quarters · filed 2017-03-14 | $89.16M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-03-31 | $21.88M 10-K · filed 2017-03-14 | $45.35M derived: sum of 2 quarters · filed 2017-03-14 | $68.09M derived: sum of 3 quarters · filed 2017-03-14 | $90.88M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2014-12-31 | $23.47M 10-K · filed 2016-03-14 | $46.21M derived: sum of 2 quarters · filed 2016-03-14 | $69.00M derived: sum of 3 quarters · filed 2016-03-14 | $91.58M 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | $22.74M 10-K · filed 2016-03-14 | $23.32M 10-Q · filed 2014-11-06 | $45.53M derived: sum of 2 quarters · filed 2016-03-14 | $68.12M 10-Q · filed 2015-11-06 | $69.79M 10-Q · filed 2014-11-06 | $91.73M derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-06-30 | $22.79M 10-K · filed 2016-03-14 | $23.37M 10-Q · filed 2014-08-07 | $45.37M 10-Q · filed 2015-08-10 | $46.48M 10-Q · filed 2014-08-07 | $68.98M derived: sum of 3 quarters · filed 2016-03-14 | $91.90M derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-03-31 | $22.58M 10-K · filed 2016-03-14 | $23.11M 10-Q · filed 2014-05-08 | $46.19M derived: sum of 2 quarters · filed 2016-03-14 | $69.11M derived: sum of 3 quarters · filed 2016-03-14 | $91.18M derived: sum of 4 quarters · filed 2016-03-14 | |||
| 2013-12-31 | $23.61M 10-K · filed 2015-03-13 | $24.08M 10-K · filed 2014-03-17 | $46.53M derived: sum of 2 quarters · filed 2015-03-13 | $68.60M derived: sum of 3 quarters · filed 2015-03-13 | $92.34M 10-K · filed 2016-03-14 | $94.81M 10-K · filed 2014-03-17 | ||
| 2013-09-30 | $22.92M 10-K · filed 2015-03-13 | $23.66M 10-Q · filed 2013-11-08 | $44.99M derived: sum of 2 quarters · filed 2015-03-13 | $70.73M 10-Q · filed 2014-11-06 | $92.57M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-06-30 | $22.07M 10-K · filed 2015-03-13 | $22.63M 10-Q · filed 2013-08-09 | $47.08M 10-Q · filed 2014-08-07 | $69.66M derived: sum of 3 quarters · filed 2015-03-13 | $92.80M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2013-03-31 | $23.74M 10-K · filed 2015-03-13 | $24.45M 10-Q · filed 2013-05-09 | $47.58M derived: sum of 2 quarters · filed 2015-03-13 | $70.73M derived: sum of 3 quarters · filed 2015-03-13 | $93.34M derived: sum of 4 quarters · filed 2015-03-13 | |||
| 2012-12-31 | $23.84M 10-K · filed 2014-03-17 | $46.98M derived: sum of 2 quarters · filed 2014-03-17 | $69.59M derived: sum of 3 quarters · filed 2014-03-17 | $91.37M 10-K · filed 2015-03-13 | $93.32M 10-K · filed 2013-03-07 | |||
| 2012-09-30 | $23.14M 10-K · filed 2014-03-17 | $17.71M 10-Q · filed 2012-11-06 | $45.75M derived: sum of 2 quarters · filed 2014-03-17 | $69.48M 10-Q · filed 2013-11-08 | $53.16M 10-Q · filed 2012-11-06 | $91.39M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | $22.61M 10-K · filed 2014-03-17 | $17.09M 10-Q · filed 2012-08-03 | $46.34M 10-Q · filed 2013-08-09 | $35.45M 10-Q · filed 2012-08-03 | $68.25M derived: sum of 3 quarters · filed 2014-03-17 | $90.21M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | $23.73M 10-K · filed 2014-03-17 | $18.36M 10-Q · filed 2012-05-08 | $45.64M derived: sum of 2 quarters · filed 2014-03-17 | $67.60M derived: sum of 3 quarters · filed 2014-03-17 | $89.64M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2011-12-31 | $21.91M 10-K · filed 2013-03-07 | $43.87M derived: sum of 2 quarters · filed 2013-03-07 | $65.91M derived: sum of 3 quarters · filed 2013-03-07 | $89.41M 10-K · filed 2014-03-17 | $69.41M 10-K · filed 2012-03-05 | |||
| 2011-09-30 | $21.96M 10-K · filed 2013-03-07 | $16.88M 10-Q · filed 2011-11-08 | $44.00M derived: sum of 2 quarters · filed 2013-03-07 | $52.56M 10-Q · filed 2012-11-06 | $105.45M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2011-06-30 | $22.04M 10-K · filed 2013-03-07 | $17.13M 10-Q · filed 2011-08-05 | $35.68M 10-Q · filed 2012-08-03 | $83.50M derived: sum of 3 quarters · filed 2013-03-07 | $100.13M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2011-03-31 | $23.50M 10-K · filed 2013-03-07 | $18.55M 10-Q · filed 2012-05-08 | $61.46M derived: sum of 2 quarters · filed 2013-03-07 | $78.09M derived: sum of 3 quarters · filed 2013-03-07 | $94.85M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2010-12-31 | $37.96M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $54.59M derived: sum of 2 quarters · filed 2013-03-07 | $71.35M derived: sum of 3 quarters · filed 2013-03-07 | $89.26M 10-K · filed 2013-03-07 | $69.04M 10-K · filed 2012-03-05 | |||
| 2010-09-30 | $16.63M 10-Q · filed 2011-11-08 | $33.39M derived: sum of 2 quarters · filed 2011-11-08 | $51.31M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $16.76M 10-Q · filed 2011-08-05 | $34.68M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $68.51M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |